SEC Form 4 · accession 0001962413-26-000002
Structure Therapeutics Inc. · GPCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joanne Waldstreicher
Director
Period of report
Jun 17, 2026
Accepted (ET)
Jun 18, 2026 · 5:00 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001888886
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (right to buy)F1,F2,F3 | $15.00 | Jun 17, 2026 | A | 39,453 | A | — | Jun 16, 2036 | Ordinary Shares | 39,453 | 39,453 | D |
Explanation of responses
- F1The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's American Depositary Shares ("ADSs").
- F2The shares vest in equal monthly installments over the 12 months following June 17, 2026, provided that the grant will in any case be fully vested on the date immediately prior to the date of the Issuer's 2027 annual shareholder meeting,
- F3The Ordinary Shares of the Issuer may be represented by ADSs. Each ADS represents three Ordinary Shares of the Issuer.